Daniel Floryk
Overview
Explore the profile of Daniel Floryk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
125
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Floryk D, Kurosaka S, Tanimoto R, Yang G, Goltsov A, Park S, et al.
Mol Cell Endocrinol
. 2011 Jul;
345(1-2):58-67.
PMID: 21782885
We analyzed the effects of castration on epididymal white adipose tissue (WAT) in C57BL/6J mice which were fed a regular or high-fat diet. Fourteen days following surgical castration profound effects...
2.
Gao Y, Ishiyama H, Sun M, Brinkman K, Wang X, Zhu J, et al.
Radiat Oncol
. 2011 Apr;
6:39.
PMID: 21496273
Background: Perifosine is a membrane-targeted alkylphospholipid developed to inhibit the PI3K/Akt pathway and has been suggested as a favorable candidate for combined use with radiotherapy. In this study, we investigated...
3.
Floryk D, Thompson T
Int J Cancer
. 2008 Aug;
123(10):2294-302.
PMID: 18712736
Inosine 5-monophosphate dehydrogenase II, a key enzyme in the de novo synthesis of purine nucleotides, is expressed in prostate tumors and prostate cancer cells. AVN944 is a new, specific, noncompetitive...
4.
Floryk D, Thompson T
Cancer Lett
. 2008 Apr;
266(2):216-26.
PMID: 18395973
We analyzed the mechanism of action for perifosine (D-21266), a new synthetic alkylphospholipid Akt inhibitor, using LNCaP and PC-3 prostate cancer cells. Perifosine treatment of PC-3 cells resulted in cytostatic...
5.
Floryk D, Huberman E
Cancer Res
. 2005 Dec;
65(24):11588-96.
PMID: 16357169
Recently, we have reported that inosine 5'-monophosphate dehydrogenase inhibitors, such as mycophenolic acid (MPA), induce the differentiation of PC-3 cells, which are derived from a human androgen-independent prostate cancer, into...
6.
Floryk D, Huberman E
Cancer Lett
. 2005 Dec;
231(1):20-9.
PMID: 16356827
Inosine 5'-monophosphate dehydrogenase inhibitors including mycophenolic acid (MPA) are effective inducers of terminal differentiation in a variety of distinct human tumor cell types. Here, we report that MPA also induces...
7.
Floryk D, Tollaksen S, Giometti C, Huberman E
Cancer Res
. 2004 Dec;
64(24):9049-56.
PMID: 15604271
To establish a system to study differentiation therapy drugs, we used the androgen-independent human prostate PC-3 tumor cell line as a target and mycophenolic acid (MPA), tiazofurin, or ribavirin, which...
8.
Drahota Z, Chowdhury S, Floryk D, Mracek T, Wilhelm J, Rauchova H, et al.
J Bioenerg Biomembr
. 2002 May;
34(2):105-13.
PMID: 12018887
Oxidation of glycerophosphate (GP) by brown adipose tissue mitochondria in the presence of antimycin A was found to be accompanied by significant production of hydrogen peroxide. GP-dependent hydrogen peroxide production...